Roche

Coronavirus World Update, May 15: Global death toll crosses 300,000, Italy to allow movement, Japan eases restrictions

Over 4.5 million people have been confirmed to be COVID-19 positive in the world so far. Of these, 1.7 million have recovered and over 300,000 have died.

Coronavirus Global Roundup, May 4: No new cases in New Zealand, 5% rise in deaths in Canada, 27,000 new cases in the US

More than 3.5 million people have been affected by COVID-19 and more than 247,000 people have succumbed to the disease.

TCS Collaborates With Roche

TCS has entered into a collaboration with Swiss healthcare company Roche to provide services related to drug development processes.

Another setback: India rejects patent on Pfizer's arthritis drug

Pfizer is reviewing its options for further action, a Mumbai-based company spokesman said in an emailed statement.

Biocon to start selling breast cancer drug next month

CANMAb will be available at about 25 percent discount to the current list price of the reference product - Roche's Herceptin - in India, which is already significantly lower than its price in developed markets, it added.<br /><br />

India revokes Roche patent; questions high price of drug

The Intellectual Property Appellate Board (IPAB) cited a lack of evidence that the drug was any better than existing treatments and its high price as reasons for the decision.

All-cash deal: Roche to buy US biotech firm InterMune for $8.3 bn

Roche Holding AG has agreed to buy US biotech company InterMune Inc for $8.3 billion in cash, marking the latest multibillion-dollar deal in a consolidating pharmaceutical sector.<br />

Not just India: UK regulator says Roche’s new breast cancer drug too costly

The National Institute for Care and Excellence (NICE) of the UK has rejected Roche’s latest breast cancer drug Perjeta because it is too expensive.